Access to UK Biobank data by researchers based in China has sparked headlines in the UK about potential security concerns, but the risks have been overblown, according to the research organisation.

Despite significant R&D investments, pharma companies often underestimate the multifaceted challenges of bringing promising treatments to market – from securing favourable reimbursement to developing ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Trump sues the BBC for $10 billion over speech edit President Donald Trump sued the BBC for at least $10 billion in damages over edited clips of a speech that made it appear he directed supporters to ...